An Open-Label, Single-Arm Clinical Trial Evaluating the Safety and Efficacy of Amisulpride in Treating Patients With Schizophrenia and Schizoaffective Disorder Who Have Treatment-Resistant Positive Symptoms

NCT05956600 · clinicaltrials.gov ↗

NA

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Action of PI. Loss of sponsor

Conditions

Schizophrenia, Treatment-Resistant

Interventions

DRUG: Amisulpride 50 MG

Sponsor

University of California, Los Angeles

Collaborators

[object Object]